Murphy Sb
-
- Lymphoma Diagnosis and Treatment 4
- Hematology top 10%
- Acute Myeloid Leukemia Research 2
- Neurology top 10%
-
- Acute Lymphoblastic Leukemia research 4
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 1
-
- Lung Cancer Treatments and Mutations 4
-
- Cancer therapeutics and mechanisms 1
-
- Immune Response and Inflammation 1
-
- Computational Drug Discovery Methods 1
- Co-authors
- CM RubinRichard A. LarsonJosé A. Martínez-ClimentElaine MorganJW VardimanLe BeauRosemarie MickPui Ch
- Journals
- PubMed (10 papers)
- Partner nations
- United States
In The Last Decade
Murphy Sb
10 papers receiving 663 citations
Hit Papers
Peers
Comparison fields: 5 of 55
- Pathology and Forensic Medicine 470
- Hematology 145
- Neurology 189
- Public Health, Environmental and Occupational Health 284
- Genetics 103
Countries citing papers authored by Murphy Sb
This map shows the geographic impact of Murphy Sb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Murphy Sb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Murphy Sb more than expected).
Fields of papers citing papers by Murphy Sb
This network shows the impact of papers produced by Murphy Sb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Murphy Sb. The network helps show where Murphy Sb may publish in the future.
Co-authorship network
The 12 scholars most cited alongside Murphy Sb, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Clinical and prognostic significance of chromosomal abnormalities in childhood acute myeloid leukemia de novo. | 1995 | 87 |
| 2 | Phase I study of recombinant human interferon gamma in children with relapsed acute leukemia. | 1992 | 15 |
| 3 | Phase I-II study of continuous-infusion high-dose human lymphoblastoid interferon and the in vitro sensitivity of leukemic progenitors in nonlymphocytic leukemia. | 1986 | 8 |
| 4 | Advanced stage (III-IV) Burkitt's lymphoma and B-cell acute lymphoblastic leukaemia in children: kinetic and pharmacologic rationale for treatment and recent results (1979-1983). | 1985 | 4 |
| 5 | Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphomas in adults.breakdown → | 1980 | 483 |
| 6 | Kinetic studies of cells in childhood leukemias. | 1979 | 7 |
| 7 | Prognostic features and obstacles to cure of childhood non-Hodgkin's lymphoma. | 1977 | 46 |
| 8 | Management of childhood non-Hodgkin's lymphoma. | 1977 | 38 |
| 9 | Evidence for recruitment and synchronization in leukemia and solid tumors. | 1976 | 1 |
| 10 | Hodgkin's disease and the non-Hodgkin's lymphomas in childhood. | 1974 | 6 |
About Murphy Sb
Murphy Sb is a scholar working on Pathology and Forensic Medicine, Hematology and Public Health, Environmental and Occupational Health, having authored 10 papers that have together received 695 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Lung Cancer Treatments and Mutations (4 papers), Acute Myeloid Leukemia Research (2 papers), Cancer therapeutics and mechanisms (1 paper), Chronic Lymphocytic Leukemia Research (1 paper), Immune Response and Inflammation (1 paper) and Computational Drug Discovery Methods (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (470 citations), Hematology (145 citations) and Neurology (189 citations). Murphy Sb has collaborated with scholars based in United States. Frequent co-authors include CM Rubin, Richard A. Larson, José A. Martínez-Climent, Elaine Morgan, JW Vardiman, Le Beau, Rosemarie Mick, Pui Ch, LW Dow and Phillip K. Weck. Their work appears in journals such as PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.